greeksoup/ stock research
Stock research / United States / NVS / Year to 31 December 2019

Novartis AG (NVS) annual results, year to 31 December 2019: revenue USD 47,498 million, from the 20-F

Novartis AG files a 20-F with the SEC once a year, in US dollars. In the year to 31 December 2019 it reported revenue from the sale of goods of USD 47,498 million, up 5.9% on the year before. Its profit attributable to shareholders was USD 11,732 million, down 7.0%, and diluted earnings per share USD 5.06.

Revenue
USD 47,498 million
+5.9% on the year
FY2016FY2019
Operating margin
19.1%
18.7% a year earlier
FY2016FY2019
Net income
USD 11,732 million
-7.0% on the year
FY2016FY2019
Diluted EPS
USD 5.06
-5.9% on the year
FY2016FY2019

this yearthe year beforeIn US dollars as filed. Hover a bar for its figure.

Income statement (profit and loss)

Year toDec 2018 †Dec 2019
Revenue from the sale of goods44,83347,498
Cost of sales14,51014,425
Gross profit31,58934,252
Research and development8,4899,402
Selling, general and administrative13,71714,369
Operating profit8,4039,086
Profit before tax14,0958,940
Income tax1,2951,793
Profit for the year12,61411,737
Profit attributable to shareholders12,61111,732
Filing20-F20-F
USD million, from the 20-F on the SEC's EDGAR, linked in the last row, on the IFRS tags the company filed.
Read moreA line the company does not file under the standard tag is left out rather than estimated.
Year toDec 2018 †Dec 2019
Diluted EPS5.385.06
Basic EPS5.445.12
Filing20-F20-F

USD per ordinary share, as filed.

Cash flow

Year toDec 2018 †Dec 2019
Cash from operations14,27213,625
Purchase of property, plant and equipment1,2541,379
Free cash flow13,01812,246
Cash from investing-5,591-2,226
Cash from financing-4,244-13,627
Buybacks2,0365,533
Dividends paid6,9666,645
Filing20-F20-F

USD million. Free cash flow is cash from operations less the purchase of property, plant and equipment, arithmetic on the two filed lines.

Balance sheet

Year toDec 2018 †Dec 2019
Funded by
Equity attributable to shareholders78,61455,474
Non-controlling interests78.077.0
Borrowings, as filed25,66022,355
Lease liabilitiesn/a1,949
Other liabilities41,21138,515
Total equity and liabilities145,563118,370
Owned
Property, plant and equipment15,69612,069
Goodwill35,29426,524
Other intangible assets38,71928,787
Cash and cash equivalents13,27111,112
Inventories6,9565,982
Other assets35,62733,896
Total assets145,563118,370
Filing20-F20-F

USD million, at each fiscal year end.

Ratios on the filed lines

Year toDec 2018 †Dec 2019
Return on year-end equity16.0%21.1%
Effective tax rate9.2%20.1%
Filing20-F20-F

Arithmetic on the filed lines of the same year.

20-F for the year to 31 December 2019, filed 2 February 2022: the filing. The figures are in US dollars as filed.